Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance

.

Source: Artificial Cells, Blood Substitutes, and Biotechnology - April 10, 2017 Category: Biotechnology Authors: Miao Yu Shangcong Han Zhongai Kou Jialing Dai Jiao Liu Chen Wei Yitong Li Lutao Jiang Yong Sun Source Type: research